back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-19 16:53 Tx date 2025-11-14 |
$MPTH
Mapath Capital Corp. formerly Invictus Financial Inc. |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$39,200
+784,000 vol $0.05 each |
1,504,000 | |
| Filed 2025-11-19 16:52 Tx date 2025-11-14 |
$MPTH
Mapath Capital Corp. formerly Invictus Financial Inc. |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-650,000 vol |
200,000 | |
| Filed 2025-01-24 12:00 Tx date 2025-01-20 |
$MPTH
Mapath Capital Corp. (formerly Invictus Financial Inc.) |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$42,500
+850,000 vol $0.05 each |
850,000 | |
| Filed 2025-01-24 11:54 Tx date 2015-09-15 |
$MPTH
Mapath Capital Corp. (formerly Invictus Financial Inc.) |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-28 14:18 Tx date 2023-12-27 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$740.00
+37,000 vol $0.02 each |
10,501,110 | |
| Filed 2023-12-20 12:31 Tx date 2023-12-18 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+150,000 vol $0.035 each |
10,464,110 | |
| Filed 2023-07-02 16:49 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$605.00
+11,000 vol $0.055 each |
10,244,110 | |
| Filed 2023-07-02 16:47 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,780
+70,000 vol $0.054 each |
10,314,110 | |
| Filed 2023-06-29 19:05 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,355
+61,000 vol $0.055 each |
||
| Filed 2023-06-29 19:04 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+20,000 vol $0.05 each |
||
| Filed 2023-06-29 19:05 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,355
+61,000 vol $0.055 each |
10,314,110 | |
| Filed 2023-06-29 19:04 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+20,000 vol $0.05 each |
10,253,110 | |
| Filed 2023-06-21 21:25 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$120,000
+1,000,000 vol $0.12 each |
1,000,000 | |
| Filed 2021-03-23 11:01 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+1,000,000 vol $0.30 each |
||
| Filed 2023-01-19 18:53 Tx date 2022-10-04 |
$TEA
Tearlach Resources Limited |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,000
+250,000 vol $0.60 each |
||
| Filed 2023-01-19 18:51 Tx date 2022-10-04 |
$TEA
Tearlach Resources Limited |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,000
+250,000 vol $0.60 each |
||
| Filed 2023-01-19 18:18 Tx date 2022-10-03 |
$TEA
Tearlach Resources Limited |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-06 17:59 Tx date 2022-10-04 |
$TEA
Tearlach Resources Limited |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-06 18:02 Tx date 2022-10-04 |
$TEA
Tearlach Resources Limited |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2022-10-06 17:59 Tx date 2022-10-04 |
$TEA
Tearlach Resources Limited |
Chow, Paul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|